Recently, Yanagida et al. reported that cytoskeletal claudin and occludin decreased in the absence of S1PR1 [59] without S1PR2, so S1P may prioritize targeting S1PR1, which has a defensive impact against ACD, as reported previously [42]. The gene discussed is S1PR1; the disease is granular corneal dystrophy type II.